Lisa J. Crawford
Belfast, NIR, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Extracellular vesicles in multiple myeloma: pathogenesis and therapeutic application.
Journal: The FEBS journal
Published: October 02, 2024
TRIM33 loss in multiple myeloma is associated with genomic instability and sensitivity to PARP inhibitors.
Journal: Scientific reports
Published: January 04, 2024
Metabolic Alterations in Multiple Myeloma: From Oncogenesis to Proteasome Inhibitor Resistance.
Journal: Cancers
Published: February 13, 2023
The Ubiquitin Proteasome System in Genome Stability and Cancer.
Journal: Cancers
Published: April 02, 2021
The E3 ligase HUWE1 inhibition as a therapeutic strategy to target MYC in multiple myeloma.
Journal: Oncogene
Published: March 31, 2020
TRAF6 Silencing Attenuates Multiple Myeloma Cell Adhesion to Bone Marrow Stromal Cells.
Journal: International journal of molecular sciences
Published: December 06, 2018
TRIM proteins in blood cancers.
Journal: Journal of cell communication and signaling
Published: October 13, 2017
Separation and Enrichment of Hematopoietic Stem Cells for CCN Studies.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: October 14, 2016
The role of the CCN family of proteins in blood cancers.
Journal: Journal of cell communication and signaling
Published: July 15, 2016
Last Updated: 09/26/2026